TABLE 2.
Monthly percentage change of new cases and pathology notifications to the Nordic cancer registries, comparing 2020 vs 2019
| Denmark | Norway | Sweden a | Finland | Iceland b | Faroes c | ||
|---|---|---|---|---|---|---|---|
| Perc. change (95% CI) | Perc. change (95% CI) | Perc. change (95% CI) | Perc. change (95% CI) | Perc. change (95% CI) | Perc. change (95% CI) | P‐value d | |
| Cases malignant | |||||||
| Jan | −1.8 (−6.1, 2.8) | 3.5 (−1.6, 8.8) | −1.7 (−5.3, 1.9) | −4.2 (−9.1, 0.9) | 6.3 (−14.7, 32.5) | −6.3 (−43.0, 54.3) | .275 |
| Feb | 4.4 (−0.5, 9.6) | 6.2 (0.7, 12.0) | 0.5 (−3.3, 4.4) | 2.9 (−2.6, 8.6) | −4.7 (−24.6, 20.6) | .467 | |
| Mar | −1.7 (−6.2, 3.1) | 0.9 (−4.4, 6.4) | −4.3 (−7.9,−0.6) | 6.3 (0.8, 12.1) | −13.4 (−31.7, 9.8) | 29.2 (−24.2, 120.1) | .019 |
| Apr | −15.7 (−20.0,−11.3) | −15.3 (−20.0,−10.4) | −25.0 (−28.1,−21.9) | −11.3 (−16.1,−6.3) | −17.2 (−35.6, 6.5) | <.001 | |
| May | −13.6 (−17.6,−9.4) | −14.3 (−18.8,−9.5) | −31.2 (−33.9,−28.3) | −24.2 (−28.2,−20.0) | −10.1 (−27.9, 12.2) | 17.7 (−30.0, 97.9) | <.001 |
| Jun | 12.6 (7.4, 18.0) | 9.1 (3.5, 15.0) | −1.6 (−5.5, 2.4) | −1.9 (−7.0, 3.5) | 19.3 (−5.1, 49.9) | <.001 | |
| Jul | 3.0 (−1.9, 8.2) | −2.0 (−7.5, 3.8) | −9.3 (−13.0,−5.3) | −1.1 (−6.4, 4.5) | 10.7 (−13.7, 41.9) | 29.4 (−31.3, 143.7) | .002 |
| Aug | 5.4 (0.5, 10.6) | 0.3 (−5.1, 6.1) | −4.5 (−8.4,−0.5) | −9.6 (−14.3,−4.6) | 8.5 (−14.6, 37.9) | <.001 | |
| Sep | 9.1 (4.2, 14.1) | −2.5 (−7.5, 2.7) | 5.3 (1.4, 9.3) | 1.5 (−3.5, 6.8) | 12.2 (−10.1, 40.2) | −42.6 (−67.8, 2.6) | .018 |
| Oct | −3.8 (−8.1, 0.7) | −0.8 (−5.8, 4.3) | −6.5 (−9.8,−3.0) | −3.8 (−8.6, 1.1) | 5.2 (−14.3, 29.1) | .363 | |
| Nov | 5.5 (0.8, 10.4) | 3.2 (−2.0, 8.6) | 4.9 (1.1, 9.0) | −0.8 (−5.7, 4.5) | 6.7 (−13.8, 32.0) | −27.7 (−59.3, 28.5) | .429 |
| Dec | 11.1 (5.8, 16.6) | 4.0 (−1.5, 9.8) | 1.5 (−2.5, 5.6) | 6.6 (0.9, 12.7) | 34.3 (6.2, 69.9) | .014 | |
| TOTAL Jan‐Dec | 1.1 (−0.3, 2.4) | −0.7 (−2.2, 0.9) | −6.2 (−7.2,−5.1) | −3.6 (−5.1,−2.1) | 4.2 (−2.4, 11.3) | −4.0 (−23.2, 19.9) | <.001 |
| TOTAL Mar‐Dec | 1.0 (−0.5, 2.6) | −1.8 (−3.5,−0.1) | −7.3 (−8.5,−6.2) | −4.2 (−5.7,−2.5) | 4.9 (−2.4, 12.7) | −3.4 (−24.7, 23.8) | <.001 |
| Cases in situ | |||||||
| Jan | 3.3 (−5.7, 13.1) | 4.0 (−3.6, 12.2) | −1.1 (−6.2, 4.4) | N/A | 31.3 (−20.7, 117.2) | N/A e | .494 |
| Feb | 24.7 (12.9, 37.8) | 3.6 (−4.4, 12.4) | 7.8 (1.9, 14.0) | N/A | 67.8 (−4.0, 193.3) | .012 | |
| Mar | −2.0 (−10.8, 7.8) | −11.8 (−18.6,−4.4) | 0.6 (−4.9, 6.3) | N/A | −38.6 (−65.9, 10.4) | N/A e | .025 |
| Apr | −28.9 (−36.1,−20.9) | −25.1 (−31.4,−18.3) | −23.7 (−28.1,−19.0) | N/A | −51.9 (−75.2,−6.7) | .378 | |
| May | −16.6 (−24.4,−8.1) | −16.1 (−22.6,−9.1) | −25.9 (−30.1,−21.5) | N/A | −20.5 (−54.6, 39.2) | N/A e | .048 |
| Jun | 2.6 (−6.5, 12.6) | 12.5 (4.0, 21.7) | −5.7 (−11.1,−0.0) | N/A | 79.0 (4.5, 206.7) | <.001 | |
| Jul | 0.0 (−10.6, 11.8) | −2.2 (−11.6, 8.1) | −19.2 (−24.8,−13.1) | N/A | 11.1 (−41.2, 110.0) | N/A e | .002 |
| Aug | −3.7 (−12.5, 6.1) | −12.6 (−19.5,−5.1) | −17.9 (−23.0,−12.5) | N/A | −11.5 (−49.5, 55.0) | .060 | |
| Sep | 14.0 (4.0, 25.0) | 7.9 (0.2, 16.1) | −6.5 (−11.4,−1.2) | N/A | 9.1 (−30.3, 70.8) | N/A e | <.001 |
| Oct | −7.9 (−16.1, 1.0) | −3.4 (−10.0, 3.7) | −19.2 (−23.4,−14.7) | N/A | 18.8 (−25.8, 90.0) | <.001 | |
| Nov | 2.8 (−5.9, 12.3) | 3.3 (−3.9, 11.1) | −12.6 (−17.3,−7.8) | N/A | −5.3 (−39.9, 49.4) | N/A e | <.001 |
| Dec | 7.7 (−2.8, 19.4) | 11.7 (2.6, 21.6) | −6.8 (−12.3,−1.1) | N/A | −12.9 (−53.7, 63.8) | .003 | |
| TOTAL Jan‐Dec | −0.8 (−3.5, 2.0) | −2.5 (−4.7,−0.2) | −10.9 (−12.3,−9.4) | N/A | 3.3 (−11.4, 20.4) | 45.7 (−30.8, 207.0) | <.001 |
| TOTAL Mar‐Dec | −3.4 (−6.3,−0.4) | −3.7 (−6.1,−1.3) | −13.8 (−15.3,−12.1) | N/A | −4.0 (−18.9, 13.6) | 87.5 (−20.5, 342.2) | <.001 |
| Notifications malignant | Malignant and in situ | ||||||
| Jan | −1.2 (−4.3, 2.1) | 4.4 (1.1, 7.9) | −0.3 (−3.0, 2.4) | −5.8 (−9.2,−2.3) | 15.9 (−2.1, 37.1) | −7.0 (−39.5, 43.1) | <.001 |
| Feb | 3.9 (0.3, 7.5) | 6.6 (2.9, 10.3) | 1.0 (−1.8, 3.9) | 2.7 (−1.2, 6.7) | 7.4 (−10.4, 28.7) | .201 | |
| Mar | 2.1 (−1.2, 5.6) | 7.3 (3.7, 11.0) | 0.6 (−2.2, 3.4) | 0.2 (−3.6, 4.0) | −5.8 (−21.3, 12.9) | 46.7 (−7.3, 132.2) | .026 |
| Apr | −10.8 (−14.0,−7.5) | −9.7 (−12.8,−6.4) | −16.3 (−18.7,−13.8) | −8.7 (−12.2,−5.1) | −3.5 (−20.4, 17.0) | .001 | |
| May | −15.2 (−18.1,−12.2) | −8.6 (−11.7,−5.5) | −25.9 (−28.0,−23.6) | −25.8 (−28.7,−22.9) | −11.5 (−25.5, 5.2) | 22.2 (−21.3, 89.9) | <.001 |
| Jun | 10.4 (6.7, 14.1) | 5.0 (1.5, 8.6) | −4.5 (−7.3,−1.7) | −7.1 (−10.5,−3.5) | 27.7 (7.0, 52.5) | <.001 | |
| Jul | 2.1 (−1.4, 5.7) | 1.0 (−2.6, 4.7) | −11.6 (−14.3,−8.8) | −6.8 (−10.3,−3.1) | 21.8 (0.8, 47.2) | 14.1 (−34.3, 98.1) | <.001 |
| Aug | 3.2 (−0.2, 6.8) | 1.6 (−2.0, 5.3) | −8.0 (−10.7,−5.1) | −13.5 (−16.8,−10.0) | 10.0 (−8.7, 32.7) | <.001 | |
| Sep | 9.1 (5.6, 12.7) | −2.6 (−5.9, 0.7) | 5.7 (2.8, 8.7) | 7.2 (3.4, 11.2) | 19.5 (0.8, 41.6) | −31.8 (−57.1, 8.4) | <.001 |
| Oct | −5.6 (−8.6,−2.5) | −7.9 (−10.8,−4.8) | −11.2 (−13.6,−8.8) | −4.1 (−7.5,−0.6) | 12.0 (−4.5, 31.3) | .001 | |
| Nov | 4.3 (0.9, 7.7) | 6.2 (2.7, 9.8) | −3.0 (−5.6,−0.2) | −6.6 (−10.0,−3.0) | 4.9 (−11.0, 23.7) | −33.6 (−59.2, 8.0) | <.001 |
| Dec | 12.8 (8.9, 16.7) | 7.0 (3.3, 10.9) | 5.3 (2.2, 8.4) | 0.1 (−3.8, 4.1) | 32.9 (11.0, 59.1) | <.001 | |
| TOTAL Jan‐Dec | 1.1 (0.1, 2.1) | 0.7 (−0.3, 1.7) | −5.8 (−6.6,−5.1) | −5.9 (−6.9,−4.8) | 10.3 (4.8, 16.0) | −2.3 (−19.1, 18.0) | <.001 |
| TOTAL Mar‐Dec | 1.1 (−0.0, 2.1) | −0.3 (−1.4, 0.8) | −7.1 (−7.9,−6.3) | −6.7 (−7.8,−5.6) | 9.9 (4.0, 16.2) | −1.1 (−19.9, 22.0) | <.001 |
| Notifications in situ | |||||||
| Jan | 0.8 (−5.6, 7.7) | 5.8 (0.5, 11.5) | N/A | N/A | 50.0 (0.2, 124.5) | N/A e | .106 |
| Feb | 19.6 (11.2, 28.5) | 4.2 (−1.4, 10.2) | N/A | N/A | 74.2 (12.0, 170.9) | .002 | |
| Mar | 0.3 (−6.3, 7.4) | −6.2 (−11.2,−0.9) | N/A | N/A | −25.6 (−53.6, 19.3) | N/A e | .183 |
| Apr | −22.3 (−28.0,−16.1) | −16.7 (−21.4,−11.6) | N/A | N/A | −40.5 (−64.5,−0.3) | .176 | |
| May | −15.0 (−20.9,−8.7) | −12.5 (−17.2,−7.5) | N/A | N/A | −26.8 (−54.3, 17.2) | N/A e | .641 |
| Jun | 8.7 (1.6, 16.4) | 4.6 (−1.0, 10.5) | N/A | N/A | 60.8 (3.7, 149.5) | .120 | |
| Jul | 2.6 (−5.1, 11.0) | −9.8 (−15.8,−3.3) | N/A | N/A | 50.0 (−12.5, 157.3) | N/A e | .014 |
| Aug | 3.3 (−3.6, 10.7) | −17.9 (−22.5,−13.0) | N/A | N/A | −15.9 (−48.2, 36.7) | <.001 | |
| Sep | 9.6 (2.5, 17.1) | −2.8 (−7.8, 2.4) | N/A | N/A | 41.6 (−0.2, 100.9) | N/A e | .004 |
| Oct | −5.7 (−11.8, 0.8) | −12.1 (−16.5,−7.5) | N/A | N/A | 23.3 (−15.5, 79.9) | .069 | |
| Nov | 4.3 (−2.2, 11.2) | −3.0 (−7.9, 2.1) | N/A | N/A | 18.9 (−17.5, 71.3) | N/A e | .141 |
| Dec | 14.9 (6.9, 23.5) | 5.7 (−0.3, 12.1) | N/A | N/A | 7.8 (−32.3, 71.5) | .216 | |
| TOTAL Jan‐Dec | 1.4 (−0.6, 3.5) | −5.1 (−6.6,−3.6) | N/A | N/A | 16.4 (2.9, 31.7) | 57.9 (−21.9, 219.2) | <.001 |
| TOTAL Mar‐Dec | −0.1 (−2.2, 2.2) | −7.2 (−8.8,−5.5) | N/A | N/A | 8.6 (−5.2, 24.4) | 88.9 (−15.8, 323.7) | <.001 |
Note: Both men and women, ages 18+.
Abbreviations: N/A, not available; Perc. change, percentage change.
a
Sweden: Cases from malignant and in situ tumours separately. Notifications from combined malignant and in situ tumours.
b
Iceland: Comparison to average numbers 2017‐2019.
c
Faroes: Comparison to average numbers 2017‐2019 in bimonthly intervals (Jan/Feb, Mar/Apr, May/Jun, Jul/Aug, Sep/Oct, Nov/Dec).
d
Tests excluding the Faroe Islands, due to bimonthly intervals.
e
Faroes: Bimonthly numbers of cases and notifications of in situ diagnoses not presented due to small numbers.